2021
DOI: 10.1016/j.bone.2021.116170
|View full text |Cite
|
Sign up to set email alerts
|

Low bone mass in Noonan syndrome children correlates with decreased muscle mass and low IGF-1 levels

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
24
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(27 citation statements)
references
References 47 publications
2
24
0
Order By: Relevance
“…There was also a significant positive association ( β =0.3855, P <0.001) between BMD and SMI, suggesting a lower rate of osteoporosis among individuals with higher SMI or lower BFP. This result is consistent with most prior studies ( 16 , 33 , 34 ).…”
Section: Discussionsupporting
confidence: 94%
“…There was also a significant positive association ( β =0.3855, P <0.001) between BMD and SMI, suggesting a lower rate of osteoporosis among individuals with higher SMI or lower BFP. This result is consistent with most prior studies ( 16 , 33 , 34 ).…”
Section: Discussionsupporting
confidence: 94%
“…Physical and radiography examinations of the child showed a short neck, scoliosis, valgus scapula, cubitus valgus and genu valgum, and thorax malformation, all of which were consistent with patients with PTPN11 mutations (15)(16)(17). However, the concurrent SEC24D gene mutation also played a major role in the skeletal development of this patient, such as wormain bones, pelvis malformation and possible low bone mass.…”
Section: Discussionsupporting
confidence: 62%
“…The exact cause of the reported increased fracture rate in the nondysplastic bones in some individuals with NF1 is not known. There are multiple studies that show reduced bone density in NF1 (Armstrong et al, 2013;Brunetti-Pierri et al, 2008;Caffarelli et al, 2010;Dulai et al, 2007;Heervä, Koffert, et al, 2012;Illés, Halmai, de Jonge, & Dubousset, 2001;Kuorilehto et al, 2005;Lammert et al, 2005;Stevenson et al, 2005;Stevenson et al, 2007;Tucker et al, 2009;Yilmaz, Ozmen, Bora Goksan, & Eskiyurt, 2007), and this is also observed in some of the other RASopathies (Delagrange et al, 2021;Leoni et al, 2014;…”
Section: Neurofibromatosis Typementioning
confidence: 93%
“…Although the musculoskeletal system is affected, bone health in NS has not been adequately investigated. Only a few studies described reduced BMD /bone impairment in NS, and these involved primarily children and hence long-term consequences and risk of fractures during adult age are unknown (Baldassarre, Mussa, Carli, Molinatto, & Ferrero, 2017;Choudhry et al, 2012;Delagrange et al, 2021;Noordam et al, 2002;Stevenson, Schwarz, et al, 2011). concentrations (Camacho et al, 2020).…”
Section: Noonan Syndromementioning
confidence: 99%